Bill119th CongressFiled Jun 8, 2026
H.R. 9190
To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedJun 8, 2026
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Harshbarger, Diana [R-TN-1](R-TN)Sponsor
1 cosponsor
1cosponsors1committees3actions